For context, most oral diabetes medications reduce HbA1c by 0.5-1.5%
The research on GLP-1s impact on addictive behaviors creates new treatment possibilities for patients facing substance use challenges alongside weight concerns
GLP-1 medications are typically administered once weekly via a subcutaneous injection, meaning a small injection just beneath the skin that causes minimal discomfort compared to intramuscular injections
The actual milligram dose depends entirely on your formulation concentration
Weight loss can improve obstructive sleep apnea, joint pain, and cardiovascular function, which may indirectly boost energy levels
its presence amplifies the risk of T2D incident by approximately twofold [1, 6, 9, 129131]